// App-Quantinova.ai

238P : CHARACTERIZATION OF CIRCULATING TUMOR CELLS (CTCS) OF METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) PATIENTS IN FIRST, SECOND & THIRD LINE SYSTEMIC THERAPIES

Researchers

Presenter

  • H.I. Scher

Principal Investigators

  • J. Louw

  • R. Krupa

  • R.M. Bambury

  • D. Danila

  • D.E. Rathkopf

  • Z. Arslan

  • N.A. Schreiber

  • A. Jendrisak

  • D. Marrinucci

  • R. Dittamore

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Translational Resear

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved